¼¼°èÀÇ ¸é¿ªÄ§°­ ½ÃÀå
Immunoprecipitation
»óǰÄÚµå : 1768559
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¸é¿ªÄ§°­ ½ÃÀåÀº 2030³â±îÁö 10¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 7¾ï 1,600¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¸é¿ªÄ§°­ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 5.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 10¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ½Ã¾àÀº CAGR 5.9%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 4¾ï 5,790¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ŰƮ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 6.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 1¾ï 8,610¸¸ ´Þ·¯, Áß±¹Àº CAGR 9.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¸é¿ªÄ§°­ ½ÃÀåÀº 2024³â¿¡´Â 1¾ï 8,610¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 9.0%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 2¾ï 3,250¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.5%¿Í 4.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¸é¿ªÄ§°­ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ºÐÀÚ»ý¹°ÇÐ ¿¬±¸¿¡ ¸é¿ªÄ§°­ÀÌ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¸é¿ªÄ§°­(IP)Àº ºÐÀÚ»ý¹°ÇÐ ¹× »ýÈ­Çп¡¼­ º¹ÀâÇÑ »ý¹°ÇÐÀû »ùÇÿ¡¼­ ƯÁ¤ ´Ü¹éÁúÀ» ºÐ¸®ÇÏ¿© ¿¬±¸ÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ±â¼úÀÔ´Ï´Ù. ¿øÇÏ´Â ´Ü¹éÁú¿¡ ƯÀÌÀûÀ¸·Î °áÇÕÇÏ´Â Ç×ü¸¦ »ç¿ëÇÏ¿© ¿¬±¸ÀÚ´Â ´Ü¹éÁúÀ» "Ç®´Ù¿î"ÇÏ¿© Ãß°¡ ¿¬±¸¸¦ À§ÇØ ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸é¿ªÄ§°­Àº ´Ü¹éÁú °£ »óÈ£ÀÛ¿ë, ¹ø¿ª ÈÄ º¯Çü, ½ÅÈ£Àü´Þ °æ·Î ¿¬±¸¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ¾Ï ¿¬±¸, ÀǾàǰ °³¹ß, ±âÃÊ »ý¹°ÇÐ ¿¬±¸¿¡¼­ ¸Å¿ì Áß¿äÇÑ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸é¿ªÄ§°­Àº ´Ü¹éÁúÀ» ¿ø·¡ÀÇ »óÅ·ΠÁ¶»çÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ» Á¦°øÇÔÀ¸·Î½á ¼¼Æ÷ ±â´É ¹× Áúº´ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí, ¿¬±¸ÀÚµéÀÌ ÀáÀçÀûÀÎ Ä¡·á Ç¥ÀûÀ» ½Äº°Çϰí Áúº´ ÁøÇàÀ» ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ¾î¶»°Ô ¸é¿ªÄ§°­ ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

Ç×ü, ½Ã¾à ¹× °ËÃâ ¹æ¹ýÀÇ ±â¼ú ¹ßÀüÀº ¸é¿ªÄ§°­ ±â¼úÀÇ Á¤È®¼º, È¿À²¼º ¹× ½Å·Ú¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. °íģȭµµ ´ÜŬ·Ð Ç×ü ¹× ÀçÁ¶ÇÕ Ç×üÀÇ °³¹ß·Î IP ºÐ¼®ÀÇ Æ¯À̼º°ú ÀçÇö¼ºÀÌ Å©°Ô Çâ»óµÇ¾î ¿¬±¸ÀÚµéÀº ´õ ³ôÀº Á¤È®µµ·Î ´Ü¹éÁúÀ» Ç¥ÀûÀ¸·Î »ïÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ Àڱ⠺ñµå¿Í °¡±³ ½Ã¾àÀÇ ¹ßÀüÀ¸·Î ¸é¿ª ħÀü °úÁ¤ÀÌ ´Ü¼øÈ­µÇ°í, ¹è°æ ÀâÀ½ÀÌ °¨¼ÒÇϰí, Ç¥Àû ´Ü¹éÁúÀÇ ¼öÀ²ÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ Áú·®ºÐ¼®°ú ¸é¿ª ħÀü(IP-MS)ÀÇ ÅëÇÕÀº ´Ü¹éÁúÀÇ µ¿Á¤°ú Á¤·®À» µ¿½Ã¿¡ °¡´ÉÇÏ°Ô ÇÏ¿© ´Ü¹éÁú º¹ÇÕü ¹× ½ÅÈ£ Àü´Þ ³×Æ®¿öÅ©¿¡ ´ëÇÑ ´õ ±íÀº ÀλçÀÌÆ®¸¦ Á¦°øÇÔÀ¸·Î½á ÀÌ ºÐ¾ß¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ ´Ü¹éÁúüÇÐ, ½Å¾à°³¹ß, ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸¿¡ ¸é¿ªÄ§°­ÀÌ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ¸é¿ª ħÀü »ê¾÷ÀÇ ¼ºÀåÀ» ¾î¶»°Ô ±ÔÁ¤Çϴ°¡?

¸é¿ªÄ§°­¿¡´Â Å©·Î¸¶Æ¾ ¸é¿ªÄ§°­(ChIP), °øµ¿ ¸é¿ªÄ§°­(Co-IP), RNA ¸é¿ªÄ§°­(RIP)ÀÌ ÀÖÀ¸¸ç, °øµ¿ ¸é¿ªÄ§°­Àº ´Ü¹éÁú °£ »óÈ£ÀÛ¿ëÀ» ¿¬±¸ÇÒ ¼ö ÀÖÀ¸¹Ç·Î °¡Àå ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¸é¿ªÄ§ÀüÀº ½Å¾à°³¹ß, ´Ü¹éÁúüÇÐ ¿¬±¸, Áúº´ Áø´Ü¿¡ Àû¿ëµÇ¸ç, ´Ü¹éÁúüÇÐ ¿¬±¸´Â Áúº´ ¸ÞÄ¿´ÏÁòÀ» ÀÌÇØÇϱâ À§ÇÑ ´Ü¹éÁú »óÈ£ÀÛ¿ë ¿¬±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ¿¡´Â Çмú¿¬±¸±â°ü, Á¦¾àȸ»ç, CRO(ÀǾàǰ °³¹ß À§Å¹±â°ü) µîÀÌ Æ÷ÇԵǸç, Á¦¾àȸ»ç´Â ½Å¾à°³¹ß ¹× ¿¬±¸°³¹ß °úÁ¤¿¡¼­ IP Ȱ¿ëÀ» ´Ã¸®°í ÀÖÀ¸¸ç, ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¸é¿ªÄ§°­ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¸é¿ª ħÀü ½ÃÀåÀÇ ¼ºÀåÀº ´Ü¹éÁúüÇÐ ¿¬±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Ç×ü ±â¼úÀÇ ¹ßÀü, ½Å¾à °³¹ß ¹× ¹ÙÀÌ¿À¸¶Ä¿ ½Äº°¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¿¬±¸ÀÚµéÀÌ ´Ü¹éÁúÀÇ »óÈ£ÀÛ¿ë°ú Áúº´¿¡¼­ÀÇ ¿ªÇÒÀ» ÀÌÇØÇÏ´Â µ¥ ÁýÁßÇÔ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ´Â ¸é¿ªÄ§°­ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¸´Ù ƯÀÌÀûÀÎ Ç×ü ¹× °³¼±µÈ ½Ã¾àÀÇ °³¹ß°ú °°Àº ±â¼ú ¹ßÀüÀ¸·Î IP´Â ´õ¿í Ä£¼÷Çϰí È¿À²ÀûÀÌ µÇ¾ú½À´Ï´Ù. Áú·®ºÐ¼®±â ¹× ±âŸ ÷´Ü °ËÃâ ¹æ¹ýÀÇ ÅëÇÕÀº º¹ÀâÇÑ ´Ü¹éÁú ³×Æ®¿öÅ©¿¡ ´ëÇÑ ¿¬±¸ ´É·ÂÀ» Çâ»ó½ÃÄÑ Çмú¿¬±¸ ¹× Á¦¾à ¿¬±¸¿¡¼­ÀÇ IP äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾Ï ¿¬±¸¿Í ¸ÂÃã ÀÇ·á ºÐ¾ß¿¡¼­ IPÀÇ È°¿ëÀÌ Áõ°¡Çϸ鼭 ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

ÄÄÆ÷³ÍÆ®(½Ã¾à, ŰƮ, ºÎ¼Óǰ); ÃÖÁ¾ »ç¿ë(Çмú¡¤¿¬±¸±â°ü, Á¦¾à¡¤¹ÙÀÌ¿ÀÆÄ¸¶ ±â¾÷, °è¾à ¿¬±¸±â°ü)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå°ú °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Immunoprecipitation Market to Reach US$1.0 Billion by 2030

The global market for Immunoprecipitation estimated at US$716.0 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$457.9 Million by the end of the analysis period. Growth in the Kits segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$186.1 Million While China is Forecast to Grow at 9.0% CAGR

The Immunoprecipitation market in the U.S. is estimated at US$186.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$232.5 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Immunoprecipitation Market - Key Trends and Drivers Summarized

Why Is Immunoprecipitation Essential in Molecular Biology Research?

Immunoprecipitation (IP) is a critical technique used in molecular biology and biochemistry to isolate and study specific proteins from complex biological samples. It involves using an antibody that specifically binds to the protein of interest, allowing researchers to “pull down” the protein and analyze it for further study. Immunoprecipitation is widely used for studying protein-protein interactions, post-translational modifications, and signaling pathways, making it an invaluable tool in cancer research, drug development, and basic biological research. By providing a means to study proteins in their native state, immunoprecipitation offers insights into cellular functions and disease mechanisms, helping researchers identify potential therapeutic targets and better understand disease progression.

How Are Technological Innovations Shaping the Immunoprecipitation Market?

Technological advancements in antibodies, reagents, and detection methods are enhancing the precision, efficiency, and reliability of immunoprecipitation techniques. The development of high-affinity monoclonal antibodies and recombinant antibodies has significantly improved the specificity and reproducibility of IP assays, allowing researchers to target proteins with greater accuracy. Additionally, advancements in magnetic beads and cross-linking reagents have simplified the immunoprecipitation process, reducing background noise and improving the yield of target proteins. The integration of mass spectrometry with immunoprecipitation (IP-MS) has also revolutionized the field by enabling the simultaneous identification and quantification of proteins, providing deeper insights into protein complexes and signaling networks. These innovations are expanding the applications of immunoprecipitation in proteomics, drug discovery, and biomarker research.

How Do Market Segments Define the Growth of the Immunoprecipitation Industry?

Types of immunoprecipitation include chromatin immunoprecipitation (ChIP), co-immunoprecipitation (Co-IP), and RNA immunoprecipitation (RIP), with co-immunoprecipitation being the most widely used due to its ability to study protein-protein interactions. Applications of immunoprecipitation span across drug discovery, proteomics research, and disease diagnostics, with proteomics research holding the largest market share due to the growing demand for protein interaction studies in understanding disease mechanisms. End-users include academic research institutes, pharmaceutical companies, and contract research organizations (CROs), with pharmaceutical companies driving demand as they increasingly use IP in drug discovery and development processes.

What Factors Are Driving the Growth in the Immunoprecipitation Market?

The growth in the immunoprecipitation market is driven by several factors, including the rising demand for proteomics research, advancements in antibody technologies, and the growing focus on drug discovery and biomarker identification. As researchers focus on understanding protein interactions and their role in disease, the demand for reliable immunoprecipitation techniques is increasing. Technological advancements, such as the development of more specific antibodies and improved reagents, are making IP more accessible and efficient. The integration of mass spectrometry and other advanced detection methods is also enhancing the ability to study complex protein networks, driving the adoption of IP in academic and pharmaceutical research. Furthermore, the increasing use of IP in cancer research and personalized medicine is contributing to the expansion of the market.

SCOPE OF STUDY:

The report analyzes the Immunoprecipitation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents, Kits, Accessories); End-Use (Academic & Research Institutes, Pharma & Biopharma Companies, Contract Research Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â